AstraZeneca has overhauled its local management in China in a bid to move on from recent scandals and revive sales after the arrest of its president in the country.
阿斯利康(AstraZeneca)已改组其manbetx3.0 业务管理层，以求从近期的丑闻中走出来，重振销售。此前这家制药商的manbetx3.0 区总裁被捕。
您已阅读5%（228字），剩余95%（4229字）包含更多重要信息，订阅以继续探索完整内容，并享受更多专属服务。